A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Trial details
- Registry ID
- NCT06565611
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of ObesityNCT06565611 | PTN | Phase 2 | Active not recruiting | 2025-02-05Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |